NCIt definition : An orally available selective estrogen receptor degrader/downregulator (SERD), with
potential antineoplastic activity. Upon oral administration, giredestrant specifically
targets and binds to the estrogen receptor (ER) and induces a conformational change
that promotes ER degradation. This prevents ER-mediated signaling and inhibits both
the growth and survival of ER-expressing cancer cells.;
UNII : 28P3DU6DB3;
InChIKey : GQCXHIKRWBIQMD-AKJBCIBTSA-N;
CAS number : 1953133-47-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1953133-47-5
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;